Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 27 2026
0mins
Should l Buy KD?
Source: PRnewswire
- Legal Investigation: Faruq & Faruqi, LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically urging investors who purchased securities between August 7, 2024, and February 9, 2026, to seek lead plaintiff status in a federal securities class action by the April 13, 2026 deadline.
- False Statement Allegations: The lawsuit alleges that Kyndryl and its executives violated federal securities laws by making false and misleading statements, including failing to disclose deficiencies in Inovio's CELLECTRA device manufacturing, which misled investors about the regulatory and commercial prospects of INO-3107.
- Stock Price Decline Impact: Following the FDA's acceptance of Inovio's Biologics License Application, Kyndryl's stock price fell by 24.45% to close at $1.73 per share, indicating market concerns about the company's future prospects and potentially diminishing investor confidence.
- Investor Rights Protection: Faruq & Faruqi encourages anyone with information regarding Kyndryl's conduct, including whistleblowers and former employees, to contact the firm to ensure investor rights are protected and to support potential recovery efforts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.370
Low
28.00
Averages
33.25
High
40.00
Current: 12.370
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating potential claims against Kyndryl Holdings, Inc., particularly for investors who purchased securities between August 1, 2024, and February 9, 2026, highlighting the firm's commitment to protecting investor rights.
- Investor Rights Reminder: The firm reminds investors that April 13, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to safeguard legal rights.
- Direct Contact Channels: Partner Josh Wilson has provided direct contact information, including phone numbers and extensions, aimed at offering legal consultation and support to affected investors, thereby enhancing investor confidence.
- Potential Litigation Impact: Such investigations could lead to legal actions against Kyndryl, which, if successful, may negatively affect the company's reputation and stock price, prompting investors to closely monitor developments for informed decision-making.
See More
Kyndryl Faces Securities Fraud Class Action Lawsuit
- Lawsuit Disclosure: Kyndryl Holdings, Inc. is facing a class action lawsuit for securities fraud, alleging that executives manipulated free cash flow metrics between August 1, 2024, and February 9, 2026, leading to materially misstated financial statements and eroding investor confidence.
- Stock Price Plunge: Following the announcement of Q1 2026 financial results on August 4, 2025, which missed analyst expectations, Kyndryl's stock dropped by 21.1%, and on February 9, 2026, the unexpected departure of the CFO and General Counsel caused a further 54% decline in stock price.
- Internal Control Deficiencies: The lawsuit claims that Kyndryl's internal controls over financial reporting were ineffective, resulting in the company's inability to file timely financial reports, which exacerbated investor concerns regarding the company's future prospects.
- Investor Action Recommendations: Kyndryl investors are encouraged to apply for lead plaintiff status in the class action lawsuit by April 13, 2026, to represent affected investors, or they may choose to remain absent from the proceedings.
See More
Kyndryl Faces Securities Class Action Lawsuits
- Filing Deadline: ClaimsFiler reminds Kyndryl investors that lead plaintiff applications must be submitted by April 13, 2026, for shares purchased between August 1, 2024, and February 9, 2026, highlighting investor concerns over the company's financial transparency.
- Disclosure Failures: Kyndryl and certain executives are accused of failing to disclose material information during the class period, violating federal securities laws, which indicates potential deficiencies in corporate governance that could erode investor confidence.
- Stock Price Plunge: On February 9, 2026, Kyndryl's stock price plummeted by $12.90, or 55%, closing at $10.59 due to the inability to timely file its 10-Q report, directly impacting investors' asset values.
- Legal Consultation Services: ClaimsFiler offers free legal consultation services to help investors understand their legal options, reflecting the increasing demand for professional legal support in securities litigation.
See More
Kyndryl Accused of Concealing Cash Flow Metrics
- Litigation Expansion: Hagens Berman has filed an expanded securities class action against Kyndryl Holdings, Inc., alleging that the company concealed true free cash flow metrics from August 1, 2024, to February 6, 2026, leading to a 55% stock collapse.
- Financial Health Concerns: The lawsuit claims that Kyndryl's reported free cash flow was a facade based on undisclosed and unsustainable cash management practices, potentially masking the company's true financial condition, which became evident after the abrupt departure of the CFO and General Counsel triggered an SEC investigation.
- Investor Action: Despite the new filing, the deadline for investors to apply as Lead Plaintiff remains unchanged at April 13, 2026, urging affected investors to act promptly to safeguard their interests.
- Whistleblower Program: Whistleblowers with non-public information regarding Kyndryl may receive rewards under the SEC Whistleblower program, incentivizing insiders to contribute to the investigation by offering up to 30% of any successful recovery.
See More
Kyndryl Investors Class Action Reminder
- Executive Departures: On February 9, 2026, Kyndryl announced the immediate departure of its CFO and General Counsel, which resulted in the company being unable to timely file its quarterly report, indicating significant weaknesses in internal controls that could undermine investor confidence.
- Stock Price Plunge: Following the announcement of executive departures, Kyndryl's stock price fell by $12.90, a staggering 54.9% drop, closing at $10.59 per share, which directly inflicted substantial losses on investors.
- Misleading Financial Reports: The lawsuit alleges that Kyndryl issued materially misleading financial statements during the class period, failing to disclose significant issues with internal controls, leading to investor misjudgment regarding the company's prospects.
- Legal Action Timeline: Investors must file a motion to be appointed as lead plaintiff in the class action by April 13, 2026, to seek recovery for losses incurred due to the company's financial issues, highlighting the potential legal ramifications for the company's future.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period regarding its financial statements and internal controls, resulting in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, causing investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, ranked first in 2017 for the number of securities class action settlements, showcasing its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation in the class action.
See More
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation Launched: Faruq & Faruqi, LLP is investigating potential claims against Kyndryl Holdings, Inc., particularly for investors who purchased securities between August 1, 2024, and February 9, 2026, highlighting the firm's commitment to protecting investor rights.
- Investor Rights Reminder: The firm reminds investors that April 13, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to safeguard legal rights.
- Direct Contact Channels: Partner Josh Wilson has provided direct contact information, including phone numbers and extensions, aimed at offering legal consultation and support to affected investors, thereby enhancing investor confidence.
- Potential Litigation Impact: Such investigations could lead to legal actions against Kyndryl, which, if successful, may negatively affect the company's reputation and stock price, prompting investors to closely monitor developments for informed decision-making.
See More
Kyndryl Faces Securities Fraud Class Action Lawsuit
- Lawsuit Disclosure: Kyndryl Holdings, Inc. is facing a class action lawsuit for securities fraud, alleging that executives manipulated free cash flow metrics between August 1, 2024, and February 9, 2026, leading to materially misstated financial statements and eroding investor confidence.
- Stock Price Plunge: Following the announcement of Q1 2026 financial results on August 4, 2025, which missed analyst expectations, Kyndryl's stock dropped by 21.1%, and on February 9, 2026, the unexpected departure of the CFO and General Counsel caused a further 54% decline in stock price.
- Internal Control Deficiencies: The lawsuit claims that Kyndryl's internal controls over financial reporting were ineffective, resulting in the company's inability to file timely financial reports, which exacerbated investor concerns regarding the company's future prospects.
- Investor Action Recommendations: Kyndryl investors are encouraged to apply for lead plaintiff status in the class action lawsuit by April 13, 2026, to represent affected investors, or they may choose to remain absent from the proceedings.
See More
Kyndryl Faces Securities Class Action Lawsuits
- Filing Deadline: ClaimsFiler reminds Kyndryl investors that lead plaintiff applications must be submitted by April 13, 2026, for shares purchased between August 1, 2024, and February 9, 2026, highlighting investor concerns over the company's financial transparency.
- Disclosure Failures: Kyndryl and certain executives are accused of failing to disclose material information during the class period, violating federal securities laws, which indicates potential deficiencies in corporate governance that could erode investor confidence.
- Stock Price Plunge: On February 9, 2026, Kyndryl's stock price plummeted by $12.90, or 55%, closing at $10.59 due to the inability to timely file its 10-Q report, directly impacting investors' asset values.
- Legal Consultation Services: ClaimsFiler offers free legal consultation services to help investors understand their legal options, reflecting the increasing demand for professional legal support in securities litigation.
See More
Kyndryl Accused of Concealing Cash Flow Metrics
- Litigation Expansion: Hagens Berman has filed an expanded securities class action against Kyndryl Holdings, Inc., alleging that the company concealed true free cash flow metrics from August 1, 2024, to February 6, 2026, leading to a 55% stock collapse.
- Financial Health Concerns: The lawsuit claims that Kyndryl's reported free cash flow was a facade based on undisclosed and unsustainable cash management practices, potentially masking the company's true financial condition, which became evident after the abrupt departure of the CFO and General Counsel triggered an SEC investigation.
- Investor Action: Despite the new filing, the deadline for investors to apply as Lead Plaintiff remains unchanged at April 13, 2026, urging affected investors to act promptly to safeguard their interests.
- Whistleblower Program: Whistleblowers with non-public information regarding Kyndryl may receive rewards under the SEC Whistleblower program, incentivizing insiders to contribute to the investigation by offering up to 30% of any successful recovery.
See More
Kyndryl Investors Class Action Reminder
- Executive Departures: On February 9, 2026, Kyndryl announced the immediate departure of its CFO and General Counsel, which resulted in the company being unable to timely file its quarterly report, indicating significant weaknesses in internal controls that could undermine investor confidence.
- Stock Price Plunge: Following the announcement of executive departures, Kyndryl's stock price fell by $12.90, a staggering 54.9% drop, closing at $10.59 per share, which directly inflicted substantial losses on investors.
- Misleading Financial Reports: The lawsuit alleges that Kyndryl issued materially misleading financial statements during the class period, failing to disclose significant issues with internal controls, leading to investor misjudgment regarding the company's prospects.
- Legal Action Timeline: Investors must file a motion to be appointed as lead plaintiff in the class action by April 13, 2026, to seek recovery for losses incurred due to the company's financial issues, highlighting the potential legal ramifications for the company's future.
See More
Kyndryl Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, to apply as lead plaintiffs by April 13, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Kyndryl made materially false statements during the class period regarding its financial statements and internal controls, resulting in the inability to timely file its Quarterly Report for the quarter ended December 31, 2025, causing investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, ranked first in 2017 for the number of securities class action settlements, showcasing its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure effective legal representation in the class action.
See More
